Key Market Insights

• At present, more than 100 long-acting drug delivery technologies are being offered by companies across the globe in order to develop long-acting drugs for a myriad of disease indications
• Nearly 90% of the technologies are based on manipulation of drug release profile; majority of these technologies can support the development of long-acting injectables with dosing interval of at least a month
• In pursuit of gaining a competitive edge, industry stakeholders are actively innovating and developing novel long-acting drug delivery technologies that can be utilized across multiple therapeutic areas
• The current service providers landscape features the presence of over 40 companies, offering a wide range of development and manufacturing services for the long-acting delivery of drugs
• The market is fragmented, featuring the presence of both established players and small firms that have the expertise to develop / manufacture long-acting drugs / delivery systems for various dosage forms
• In order to cater to the evolving needs of clients, several service providers claim to be steadily expanding their existing capabilities to enhance their respective service portfolio
• The growing interest in this domain is clearly evident from the rise in partnership activity; in fact, more than 60 collaborations related to long-acting drug delivery were inked in the last three years
• ~575 scientific articles published recently signify the focused efforts being led by researchers to identify and develop novel long-acting technologies and therapeutic interventions
• Over 1,200 patents related to long-acting drug delivery have been filed / granted by various stakeholders in order to protect the intellectual property generated within this field
• 400+ grants have been awarded for the ongoing RD efforts for long acting drug delivery; University of North Carolina and John Hopkins University have emerged as the most popular recipient organizations
• The market opportunity associated with long-acting drug delivery technologies is anticipated to witness an annualized growth of nearly 13% over the next decade
• The market opportunity is expected to be well distributed across different compatible dosage forms, types of molecules supported and key geographical regions

1. 1. PREFACE

1.1.      Introduction

1.2.      Key Market Insights

1.3.      Scope of the Report

1.4.      Research Methodology

1.5.      Frequently Asked Questions

1.6.      Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1.      Chapter Overview

3.2.      Overview of Long-Acting Drug Delivery

3.3.      Long-Acting Drug Delivery Technologies

3.4.      Concluding Remarks

4. TECHNOLOGY LANDSCAPE

4.1.      Chapter Overview

4.2.      Long-Acting Drug Delivery: Technology Landscape

4.3.      Long-Acting Drug Delivery: Technology Developers Landscape

5. SERVICE PROVIDERS LANDSCAPE

5.1.      Chapter Overview

5.2.      Long-Acting Drug Delivery: Service Providers Landscape

6. TECHNOLOGY COMPETITIVENESS ANALYSIS

6.1.      Chapter Overview

6.2.      Assumptions / Key Parameters

6.3.      Methodology

6.4.      Technology Competitiveness Analysis

7. COMPANY COMPETITIVENESS ANALYSIS

7.1.      Chapter Overview

7.2.      Assumptions / Key Parameters

7.3.      Methodology

7.4.      Company Competitiveness Analysis

8. COMPANY PROFILES

8.1.      Chapter Overview

8.2.      Adare Pharma Solutions

8.2.1.   Company Overview

8.2.2.   Technology Portfolio

8.2.3.   Service Portfolio

8.2.4.   Recent Developments and Future Outlook

8.3.      AMW

8.4.      Bostal Drug Delivery

8.5.      Creative Biolabs

8.6.      ForDoz Pharma

8.7.      InnoCore Pharmaceuticals

8.8.      Integral BioSystems

8.9.      LATITUDE Pharmaceuticals

8.10.    Navin Saxena Research and Technology Centre (NSRT)

8.11.    Samyang Biopharm

9. PARTNERSHIPS AND COLLABORATIONS

9.1.      Chapter Overview

9.2.      Partnership Models

9.3.      Long-Acting Drug Delivery Technologies and Services: Partnerships and Collaborations

10. PUBLICATION ANALYSIS

10.1.    Chapter Overview

10.2.    Scope and Methodology

10.3.    Long-Acting Drug Delivery: Publication Analysis

11. PATENT ANALYSIS

11.1.    Chapter Overview

11.2.    Scope and Methodology

11.3.    Long-Acting Drug Delivery: Patent Analysis

11.4.    Patent Benchmark Analysis

11.5.    Patent Valuation Analysis

12. GRANT ANALYSIS

12.1.    Chapter Overview

12.2.    Scope and Methodology

12.3.    Long-Acting Drug Delivery: Grant Analysis

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS

13.1.    Chapter Overview

13.2.    Key Assumptions and Forecast Methodology

13.3.    Global Long-Acting Drug Delivery Technologies Market, 2023-2035

13.4.    Global Long-Acting Drug Delivery Services Market, 2023-2035

14. CONCLUSION

15. INTERVIEW TRANSCRIPTS

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/long-acting-drug-delivery-market.html

You may also be interested in the following titles:

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com